Review
Inhibitory peptides in hematopoiesis
Affiliations
- PMID: 7768302
Item in Clipboard
Review
Inhibitory peptides in hematopoiesis
Exp Hematol.
1995 Jun.
Abstract
This paper will review the present knowledge on two small chemically unrelated peptides, the pentapeptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) and the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP, Seraspenide) focusing on 1) their inhibitory effects on normal hematopoiesis, 2) their effect on malignant cells, especially leukemic cells, and 3) their potential clinical use as marrow protectors during cancer therapy.
Similar articles
-
Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.Exp Hematol. 1998 Aug;26(9):851-8. Exp Hematol. 1998. PMID: 9694506
-
The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.Mol Pharmacol. 1999 Oct;56(4):665-74. Mol Pharmacol. 1999. PMID: 10496948
-
Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.Mol Pharmacol. 1990 Sep;38(3):401-9. Mol Pharmacol. 1990. PMID: 2402229
-
[Biomolecules suppressing myelopoiesis].Acta Cient Venez. 1992;43(5):255-68. Acta Cient Venez. 1992. PMID: 1343739 Review. Spanish.
-
The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.Cancer Treat Rev. 1990 Sep;17(2-3):347-54. doi: 10.1016/0305-7372(90)90068-q. Cancer Treat Rev. 1990. PMID: 2272050 Review.
Cited by
-
AcSDKP is down-regulated in anaemia induced by Trypanosoma brucei infection in mice.Malawi Med J. 2017 Sep;29(3):259-264. doi: 10.4314/mmj.v29i3.6. Malawi Med J. 2017. PMID: 29872517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources